Navigation Links
Pharmaceutical Industry Confronting Big Challenges, Opportunities in 2012: Leaders to Convene at Groundbreaking Event on February 7-8 in New Jersey

PARSIPPANY, N.J., Jan. 11, 2012 /PRNewswire/ -- The year 2012 sets the stage for an exciting, yet challenging time for the pharmaceutical industry. To address what lies ahead in the New Year, the pharma industry's leading experts all plan to be at the Pharma Market Research Conference. This overwhelmingly popular event takes place on February 7-8 at the Hilton Parsippany Hotel in New Jersey.

Under the guidance of the esteemed advisory board with members from Alexion Pharmaceuticals, Bayer Healthcare, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Purdue Pharma, Shire Pharmaceuticals, Takeda Pharmaceuticals, Teva Health Systems and many more, the Pharma Market Research Conference is a prestigious event known for providing the best and latest information to all participants. This is the premier gathering of senior level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research.  To view the advisory board, go to:

Here's what one Merck executive said about the conference: "...a terrific opportunity to interact with fellow market research professionals and market research agencies in order to share best practices both for conducting market research and for how agencies and industry can most effectively interact. I came away feeling energized to try out new methodologies that I had learned about and to further familiarize myself with agencies that I met at the conference."

Time and time again, participants are overwhelmingly impressed with the Pharma Market Research Conference's outstanding program featuring an elite group of expert speakers who come from stellar companies like Abbott Laboratories, Alkermes, Allergan, Inc., Amylin Pharmaceuticals, Astellas Pharma, Auxilium Pharmaceuticals, Bayer Healthcare, Bristol-Myers Squibb, Cephalon, Covidien, Daiichi Sankyo, GE Healthcare Systems, GlaxoSmithKline, Johnson & Johnson, Lundbeck Inc., Mead Johnson, Merck, Millennium Pharmaceuticals, NPS Pharmaceuticals, Pfizer, Purdue Pharma, Roche, Shionogi Inc., Shire Pharmaceuticals, Takeda Pharmaceuticals, Teva Health, and many more! To view the detailed program agenda, go to:

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research. Nowhere else will you find the industry's best and brightest all under one roof!  More than 250 people came in 2011, and 2012 is expected to be even bigger and better.  For more information or to register, call + or go to:

Amy Yueh
Pharma Market Research Conference


SOURCE Pharma Market Research Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... Wound Care Market by Type (Dressings, Therapy Devices, Active ... Facility, Out-Patient Facility), and Geography - Global Forecast to ... --> --> The purpose of ... forecast of the global advanced wound care market. It ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today ... Meeting. Their Ecosystem empowers dentists to make complex business decisions by providing the tools ... receive a free fee survey with 10 procedures customized by zip code. , ...
(Date:11/30/2015)... Grove, IL (PRWEB) , ... November 30, 2015 , ... ... for an emerging pharmaceutical company. Because it is so important to this key industry ... “Success Factors in your IND Filing” on December 4th at 11am EST. , Federal ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... has verified that their Vasont Universal Integrator (VUI) extension unites with Syncro Soft’s ... and managing content as a continuous process with the latest release of oXygen® ...
(Date:11/30/2015)... California (PRWEB) , ... November 30, 2015 , ... ... a strategic alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue ... synthetic polymers, TIGR® Matrix is a long-term resorbable surgical mesh intended to support ...
(Date:11/30/2015)... ... 2015 , ... Healthjump, Inc. announced that it has acquired ... development and support company. The purchase will expand the capability to serve clients ... the services currently provided by Healthjump. , Through this purchase, ...
Breaking Medicine News(10 mins):